The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau

På svenska

Author

  • Peter Aaby
  • Per Gustafson
  • Adam Roth
  • Amabelia Rodrigues
  • Manuel Fernandes
  • Morten Sodemann
  • Birgitta Holmgren
  • Christine Stabell Benn
  • May-Lill Garly
  • Ida Maria Lisse
  • Henrik Jensen
Show all

Summary, in English

BACKGROUND: Live vaccines including BCG and measles may have non-targeted beneficial effects on childhood survival in areas with high mortality. The authors therefore undertook a survey of vaccinia scars to evaluate subsequent mortality. SUBJECTS: Based on a population census, a cohort of 1893 adults in urban Guinea-Bissau was examined in 1998 and followed until 2002. MAIN OUTCOME MEASURE: All cause mortality, excluding accidents. RESULTS: The median age of vaccinia vaccinations had been 16-18 years. Adults with a vaccinia scar had a mortality ratio (MR) of 0.60 (0.41-0.87) compared to those without any scar. The effect was stronger for women. Mortality decreased with each additional vaccinia scar (MR=0.73 (0.56-0.95)). Among 502 individuals with information on HIV infection, the age-adjusted HIV-2 prevalence was 2.45 (1.06-5.65) for those with a vaccinia scar. Control for district, ethnic group, schooling, place of birth, quality of housing and HIV status had little effect on the estimate. Since vaccinia and BCG scars could have been confused, mortality for adults with vaccinia and/or BCG scar was compared to those without, the MR being 0.61 (0.41-0.89). CONCLUSION: Known cultural or socio-economic factors possibly associated with access to vaccination had no influence on the mortality ratio for having a vaccinia scar. Hence, vaccinia vaccination may have a prolonged beneficial effect on adult survival.

Department/s

Publishing year

2006

Language

English

Pages

5718-5718

Publication/Series

Vaccine

Volume

24

Issue

29-30

Document type

Journal article

Publisher

Elsevier

Topic

  • Infectious Medicine
  • Clinical Medicine

Keywords

  • Adult mortality
  • Beneficial effects of vaccination
  • HIV-2
  • Non-targeted effects of vaccination
  • Smallpox vaccination
  • Vaccinia

Status

Published

Research group

  • Infectious Diseases Research Unit
  • Clinical Microbiology, Malmö

ISBN/ISSN/Other

  • ISSN: 1873-2518